90 related articles for article (PubMed ID: 1708922)
1. VAB-6 chemotherapy causes spurious elevation of alpha-fetoprotein associated with liver dysfunctions.
Hida S; Nishimura K; Nishio Y; Oishi K; Takeuchi H; Yoshida O
Urol Int; 1991; 46(1):1-5. PubMed ID: 1708922
[TBL] [Abstract][Full Text] [Related]
2. [False-positive elevation of alpha-fetoprotein during induction chemotherapy in patients with testicular cancer].
Hida S; Kawakita M; Oishi K; Okada Y; Takeuchi H; Okada K; Yoshida O
Hinyokika Kiyo; 1986 Dec; 32(12):1859-66. PubMed ID: 2435135
[TBL] [Abstract][Full Text] [Related]
3. [A case report of a 6-year-old boy with intracranial yolk sac tumor treated by VAB-6 regimen].
Wada H; Kubo M; Wada T; Ueno Y; Horita S; Ohki T; Munemoto S; Kuroda E; Taguchi H; Muramatsu N
No Shinkei Geka; 1995 Jan; 23(1):65-8. PubMed ID: 7531296
[TBL] [Abstract][Full Text] [Related]
4. The pattern of gamma-glutamyl transpeptidase, alkaline phosphatase, serum glutamyl oxalate transaminase and serum glutamyl pyruvate transaminase in patients with disseminated non-seminomatous testicular tumors.
van 't Sant P; Sleijfer DT; Schraffordt Koops H; Suurmeijer AJ; Willemse PH; De Bruijn HW; Marrink J; Ockhuizen T
Eur J Cancer Clin Oncol; 1984 Feb; 20(2):209-15. PubMed ID: 6200328
[TBL] [Abstract][Full Text] [Related]
5. [Case report of a non-seminomatous testicular neoplasm indicating marked efficacy of a combination chemotherapy of VBL, ACTD, BLM, CDDP and EX (VAB-4 combination therapy)].
Hayashi M; Ebihara K; Urano E
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2775-7. PubMed ID: 6210063
[TBL] [Abstract][Full Text] [Related]
6. [Modified VAB-3 combination chemotherapy of stage IV endodermal sinus tumor of the ovary].
Tsukamoto N; Imachi M; Sumioki H; Kamura T
Gan To Kagaku Ryoho; 1984 Apr; 11(4):948-51. PubMed ID: 6202244
[TBL] [Abstract][Full Text] [Related]
7. [The results of the use of bleomycin and its analogs in the VAB-6 protocol in treating testicular tumors].
Garin AM; Tiuliandin SA; Abdyldaev TA; Khlebnov AV; Kupchan DZ
Antibiot Khimioter; 1988 Nov; 33(11):855-9. PubMed ID: 2465746
[TBL] [Abstract][Full Text] [Related]
8. Advanced seminoma: treatment results, survival, and prognostic factors in 142 patients.
Mencel PJ; Motzer RJ; Mazumdar M; Vlamis V; Bajorin DF; Bosl GJ
J Clin Oncol; 1994 Jan; 12(1):120-6. PubMed ID: 7505805
[TBL] [Abstract][Full Text] [Related]
9. [VAB-6 combination chemotherapy in patients with stage II, III testicular tumor].
Hida S; Kawakita M; Takenawa J; Fukuzawa S; Okuno H; Yamauchi T; Oishi K; Nishio Y; Takeuchi H; Okada K
Hinyokika Kiyo; 1986 Dec; 32(12):1849-58. PubMed ID: 2435134
[TBL] [Abstract][Full Text] [Related]
10. Tumour marker concentration at the start of chemotherapy is a stronger predictor of treatment failure than marker half-life: a study in patients with disseminated non-seminomatous testicular cancer.
de Wit R; Sylvester R; Tsitsa C; de Mulder PH; Sleyfer DT; ten Bokkel Huinink WW; Kaye SB; van Oosterom AT; Boven E; Vermeylen K; Stoter G
Br J Cancer; 1997; 75(3):432-5. PubMed ID: 9020492
[TBL] [Abstract][Full Text] [Related]
11. [Early changes in serum alpha-fetoprotein after chemotherapy in advanced testicular tumors].
Yamazaki H; Kondo N; Imanaka K; Kuroda A; Nakauchi K; Machida T
Nihon Hinyokika Gakkai Zasshi; 1990 Jul; 81(7):1010-6. PubMed ID: 1699019
[TBL] [Abstract][Full Text] [Related]
12. Alternating cycles of etoposide plus cisplatin and VAB-6 in the treatment of poor-risk patients with germ cell tumors.
Bosl GJ; Geller NL; Vogelzang NJ; Carey R; Auman J; Whitmore WF; Herr H; Morse M; Sogani P; Chan E
J Clin Oncol; 1987 Mar; 5(3):436-40. PubMed ID: 2434627
[TBL] [Abstract][Full Text] [Related]
13. VAB-6 as initial treatment of patients with advanced seminoma.
Stanton GF; Bosl GJ; Whitmore WF; Herr H; Sogani P; Morse M; Golbey RB
J Clin Oncol; 1985 Mar; 3(3):336-9. PubMed ID: 2579214
[TBL] [Abstract][Full Text] [Related]
14. Modified VAB-3 combination chemotherapy of advanced and recurrent endodermal sinus tumors of the ovary.
Tsukamoto N; Imachi M; Uchino H; Ono M; Kamura T; Saito T; Matsukuma K
Gynecol Oncol; 1985 Mar; 20(3):336-45. PubMed ID: 2579009
[TBL] [Abstract][Full Text] [Related]
15. VAB-6 combination chemotherapy in disseminated cancer of the testis.
Vugrin D; Herr HW; Whitmore WF; Sogani PC; Golbey RB
Ann Intern Med; 1981 Jul; 95(1):59-61. PubMed ID: 6166230
[TBL] [Abstract][Full Text] [Related]
16. Reversible increase in serum alpha-fetoprotein content associated with hepatic dysfunction during chemotherapy for seminoma.
Grem JL; Trump DL
J Clin Oncol; 1986 Jan; 4(1):41-5. PubMed ID: 2416888
[TBL] [Abstract][Full Text] [Related]
17. [VAB-3 chemotherapy of endodermal sinus tumor of the ovary].
Goto Y; Imai K; Yamashita M; Konishi I; Fujii S; Noda Y; Okamura H; Mori T; Suzuki A
Nihon Gan Chiryo Gakkai Shi; 1987 Feb; 22(1):75-80. PubMed ID: 2440967
[No Abstract] [Full Text] [Related]
18. [A case of complete remission obtained with etoposide cis-platinum combination chemotherapy in advanced testicular cancer].
Iinuma S; Yamamoto H; Hagiwara M; Nakazono M
Gan To Kagaku Ryoho; 1990 Feb; 17(2):293-6. PubMed ID: 1689134
[TBL] [Abstract][Full Text] [Related]
19. [Management and drug therapy of patients with disseminated testicular tumors].
Garin AM; Lichinitser MR; Khlebnov AV; Tiuliandin SA
Vopr Onkol; 1986; 32(10):71-8. PubMed ID: 2430361
[TBL] [Abstract][Full Text] [Related]
20. VAB-6: an effective chemotherapy regimen for patients with germ-cell tumors.
Bosl GJ; Gluckman R; Geller NL; Golbey RB; Whitmore WF; Herr H; Sogani P; Morse M; Martini N; Bains M
J Clin Oncol; 1986 Oct; 4(10):1493-9. PubMed ID: 2428948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
